Evidence map›Paper›PMID 27023461›Full record

ArticleEuropean journal of clinical pharmacology2016

Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.

J Smedberg, M Bråthen, M S Waka, A F Jacobsen, G Gjerdalen, H Nordeng

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Observational
  10. Article
  11. Article
  12. Observational
  13. Observational
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J SmedbergPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
M BråthenPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
M S WakaPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
A F JacobsenDepartment of Obstetrics, Women and Children's Clinic, Ullevål, Oslo University Hospital, PO Box 4956, Nydalen, 0424, Oslo, Norway.
G GjerdalenMaternity Ward Unit, Department of Gynecology and Obstetrics, Drammen Hospital, Vestre Viken Hospital Trust, PO Box 800, 3004, Drammen, Norway.
H NordengPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.
University of Oslo · NODrammen Hospital · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere is a lack of knowledge about drug-related problems (DRPs) among pregnant and lactating women. The aim of this study was to determine the extent and type of DRPs among pregnant and lactating women in the maternity ward at two Norwegian hospitals. We also aimed to investigate which drugs were involved in the identified DRPs, and the outcome of solving the DRPs.

methodsPatient-reported treatment reviews were performed to assess the prevalence and type of DRPs among women at the two maternity wards.

resultsIn all, 212 women were included in the study, of which 89 (42 %) had experienced at least one DRP (105 DRPs in total). "Need for additional drug" (49 cases, 46.7 %) was the most frequent. The most frequent drug group involved in DRPs was drugs acting on the respiratory system, and the most common intervention was raising awareness/providing confidence/giving information during the patient-reported treatment review.

conclusionsOver four out of ten women in the maternity wards have DRPs, and many have questions about drug use during pregnancy and lactation. Many of the DRPs could probably be avoided by providing patient-reported treatment reviews to pregnant women as a part of antenatal care. Multidisciplinary collaboration including physicians, midwifes, and pharmacists in antenatal care and in maternity ward could possibly prevent DRPs and thereby promote patient safety for pregnant and lactating women.

Indexed as

AdolescentAdultCross-Sectional StudiesDrug InteractionsDrug-Related Side Effects and Adverse ReactionsDrug UtilizationFemaleHumansInappropriate PrescribingLactationMedication ErrorsNorwayObstetrics and Gynecology Department, HospitalPatient CompliancePregnancyYoung AdultDrug-related problemsMedicationPatient-reported treatment reviewsPregnancy

Identifiers

PMID27023461
OpenAlexW2329386451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.